Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

Share Price is delayed by 15 minutes
Get Live Data
4,434.00    4.00 (0.09%)
Bid:
4,430.00
Ask:
4,436.00
Spread: 6.00 (0.135%)
Market Cap: £2.07b
MGNS Live PriceLast checked at - London Stock Exchange

Intraday Morgan Sindall Group Share Chart

Director/PDMR Shareholding

18 Mar 2010 15:53

RNS Number : 8213I
Morgan Sindall PLC
18 March 2010
 



MORGAN SINDALL plc

(the "Company")

 

Notification of Transactions by Directors

 

Awards under the Morgan Sindall Executive Remuneration Plan

On 17 March 2010, directors of the Company were granted options and/or conditional share awards over ordinary shares of 5p each in the capital of the Company ("shares") under the Morgan Sindall Executive Remuneration Plan 2005 ("the Plan"). Under the Plan the directors were allowed to choose between receiving either conditional share awards or options or a mixture of both.

 

Details of the directors and the number of shares under option and/or conditional share awards granted to them under the Plan are set out below:

 

Director

Number of shares over which options awarded

Number of conditional shares awarded

John Morgan

229,728

Nil

Paul Smith

135,136

33,784

David Mulligan

79,730

19,932

Paul Whitmore

Nil

36,486

 

The exercise price for the above options is £5.55 per share. Subject to the satisfaction of an earnings per share performance condition, options will normally be exercisable for a period of 7 years from 17 March 2013. No consideration was paid for the grant of the options.

 

Conditional share awards do not have an exercise price and will normally vest on 17 March 2013 being the third anniversary of the date of grant, subject to continued employment with the Company and the satisfaction of an earnings per share performance condition.

 

No consideration was paid for the grant of the awards.

 

Following the granting of the above options and conditional share awards under the Plan these directors maintain the following beneficial interests in the issued share capital of the Company:

 

Director

Beneficial interest in the shares of the Company

% of the issued share capital of the Company

Total number of shares over which options are held

Total number of conditional share awards held

John Morgan

4,497,508

10.42

761,024

Nil

Paul Smith

217,915

0.50

454,624

84,158

David Mulligan

24,544

0.06

260,156

48,750

Paul Whitmore

62,840

0.15

1,338

89,446

 

This notification relates to transactions notified in accordance with both Disclosure Rule 3.1.4R (1) (a) and Disclosure Rule 3.1.4R (1) (c).

 

 

Contact:

 

Mary Nettleship Tel: 020 7307 9218

Company Secretary

18 March 2010

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLFEEVFITLII
Date   Source Headline
3rd Jun 202611:56 amRNSDirector/PDMR Shareholding
1st Jun 20269:27 amRNSTotal Voting Rights
27th May 20261:29 pmRNSAdmission to Trading
20th May 202611:35 amRNSIssue of Equity
7th May 202612:38 pmRNSResult of AGM
1st May 20261:33 pmRNSDirector/PDMR Shareholding
1st May 202610:57 amRNSTotal Voting Rights
20th Apr 20263:44 pmRNSHolding(s) in Company
16th Apr 20264:09 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSTrading and Outlook for 2026
14th Apr 20262:18 pmRNSAdmission to Trading
1st Apr 20269:53 amRNSTotal Voting Rights
26th Mar 20261:27 pmRNSHolding(s) in Company
24th Mar 202612:56 pmRNSAnnual Financial Report
20th Mar 202612:42 pmRNSIssue of Equity
9th Mar 20263:35 pmRNSDirector/PDMR Shareholding
9th Mar 20263:35 pmRNSDirector/PDMR Shareholding
9th Mar 20263:30 pmRNSDirector/PDMR Shareholding
9th Mar 20263:30 pmRNSDirector/PDMR Shareholding
4th Mar 20262:38 pmRNSDirector/PDMR Shareholding
4th Mar 20262:36 pmRNSDirector/PDMR Shareholding
3rd Mar 20263:33 pmRNSIssue of Equity / Admission to Trading
2nd Mar 20269:22 amRNSTotal Voting Rights
26th Feb 20269:53 amRNSDirector Declaration
25th Feb 20267:00 amRNSResults for the Full Year ended 31 December 2025
12th Feb 20267:00 amRNSTrading and Outlook for 2026
2nd Feb 20269:13 amRNSTotal Voting Rights
19th Jan 20267:00 amRNSNotice of Full Year Results
2nd Jan 202611:09 amRNSTotal Voting Rights
16th Dec 202510:16 amRNSAdditional Listing
2nd Dec 20259:12 amRNSTotal Voting Rights
25th Nov 20254:14 pmRNSHolding(s) in Company
12th Nov 20254:07 pmRNSDirector/PDMR Shareholding
3rd Nov 202510:58 amRNSTotal Voting Rights
20th Oct 202511:24 amRNSBlock listing Interim Review
20th Oct 20259:32 amRNSDirector/PDMR Shareholding
2nd Oct 20257:00 amRNSTrading Update and Outlook for 2025
1st Oct 20259:05 amRNSTotal Voting Rights
1st Sep 20258:59 amRNSTotal Voting Rights
4th Aug 20253:09 pmRNSDirector/PDMR Shareholding
1st Aug 20257:00 amRNSTotal Voting Rights
29th Jul 20257:00 amRNSResults For the Half Year (HY) Ended 30 June 2025
18th Jul 20258:40 amRNSHolding(s) in Company
1st Jul 20259:34 amRNSTotal Voting Rights
25th Jun 20258:47 amRNSAdditional Listing
24th Jun 20257:00 amRNSNotice of Half Year Results
17th Jun 20257:00 amRNSTrading Update and Outlook for 2025
16th Jun 20251:55 pmRNSDirector/PDMR Shareholding
2nd Jun 20253:45 pmRNSTotal Voting Rights
2nd Jun 202511:14 amRNSCompany Secretary Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.